In this study, it had been uncovered that cardiovascular risk factors are particularly common in patients with NAFLD, and several recent investigations have found that cardiovascular morbidity and death are more relevant than hepatic adverse events in this population. This increased cardiovascular risk should be recognized by healthcare providers. Patients should be taught because, in our experience, they become fixated on liver enzymes and overlook more critical cardiovascular issues. Weight loss and proper diabetes and dyslipidemia control might enhance liver histology and cardiovascular morbidity. Statins and histological techniques have been demonstrated to be safe in individuals with chronic liver disease in numerous recent trials, and they should not be avoided in NAFLD patients with dyslipidemia.

It amazes me how there is yet more to discover about our own body this far out in our progress as a collective specie. The article proves that histologic techniques remain to be a vital skill in advancements and discoveries of medicine no matter how many generations pass.